Skip to main content
Premium Trial:

Request an Annual Quote

DiscoveRx to Provide Cell-Based Assay Platform for NIH Chemical Genomics Program

NEW YORK, Nov. 4 (GenomeWeb News) - DiscoveRx said yesterday that the National Institutes of Health has agreed to use its PathHunter cell-based assay technology for the NIH Chemical Genomics Center as part of the NIH Molecular Libraries roadmap initiative.


PathHunter is designed for high-throughput screens to monitor cell signaling pathways. The approach has so far been applied to a range of target molecules, including kinases, transcription factors, phosphatases, and nuclear hormone receptors, DiscovRx said.


Financial terms of the agreement were not provided.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.